GALTNasdaqPharmaceutical PreparationsFiscal year ends December 31

GALECTIN THERAPEUTICS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$3.50−0.13 (-3.45%)

Close on Oct 19, 2026

Market cap: $230.23M
P/E (TTM): –
Dividend yield: –

GALECTIN THERAPEUTICS INC balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31	Q4 2016 2016-12-31	Q3 2016 2016-09-30
Cash & Equivalents	13	14	18	12	14	7.43	15	27	26	24	26	20	18	18	19	16	24	32	40	37	32	21	27	33	41	43	47	50	52	6.97	8.25	10	10	3.99	3.05	6.96	9.13	14	15	16
Cash & Short-Term Investments	13	14	18	12	14	7.43	15	27	26	24	26	20	18	18	19	16	24	32	40	37	32	21	27	33	41	43	47	50	52	6.97	8.25	10	10	3.99	3.05	6.96	9.13	14	15	16
Prepaid Expenses & Other	1.39	1.58	1.72	1.20	1.66	1.85	2.13	1.61	1.69	1.91	2.05	1.25	1.50	1.75	1.96	1.29	1.61	1.90	2.17	1.40	1.74	2.03	2.32	1.33	0.35	0.56	0.73	0.14	0.65	0.51	0.58	0.39	0.54	0.69	0.77	0.05	0.20	0.35	0.43	0.05
Total Current Assets	15	16	19	13	15	9.29	17	29	27	25	28	22	19	20	21	17	26	34	42	38	33	23	29	34	41	44	48	50	53	7.48	8.83	11	11	4.67	3.82	7.01	9.33	14	16	16
Property, Plant & Equipment	–	–	0	–	–	–	0	–	–	–	0	–	–	–	0	–	–	–	0	–	–	–	0	–	–	–	0	–	–	–	0	–	–	–	0	–	–	–	0	–
Gross Property, Plant & Equipment	–	–	0.07	–	–	–	0.07	–	–	–	0.07	–	–	–	0.07	–	–	–	0.07	–	–	–	0.07	–	–	–	0.07	–	–	–	0.07	–	–	–	0.07	–	–	–	0.07	–
Accumulated Depreciation	–	–	-0.07	–	–	–	-0.07	–	–	–	-0.07	–	–	–	-0.07	–	–	–	-0.07	–	–	–	-0.07	–	–	–	-0.07	–	–	–	-0.07	–	–	–	-0.07	–	–	–	-0.07	–
Operating Lease Right-of-Use Assets	0.12	0.01	0.02	0.04	0.05	0.07	0.02	0.03	0.04	0.05	0.05	0.06	0.07	0.08	0.09	0.09	0.10	0.11	0.01	0.02	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	–	–	–	0	–	–	–	0.00	0.00
Other Long-Term Assets	0.17	0.07	0.10	0.14	0.18	0.24	0.24	0.31	0.37	0.43	0.49	0.55	0.61	0.67	0.73	0.79	0.10	0.11	0.01	0.04	0.07	0.10	0.14	0.17	0.20	0.23	0.26	0.29	0.32	0.35	0.17	0.09	0.17	0.26	0.34	–	–	–	–	–
Total Assets	15	16	20	13	16	9.53	17	29	28	26	28	22	20	20	21	18	26	34	42	38	33	23	30	34	41	44	48	51	53	7.83	9.01	11	11	4.93	4.16	7.01	9.33	14	16	16
Accounts Payable	3.73	3.12	3.25	5.39	5.87	6.53	5.66	2.80	3.70	3.80	6.43	2.68	1.98	2.55	3.89	2.35	2.96	1.91	1.81	1.92	0.92	0.38	1.29	0.69	0.21	0.66	1.66	0.35	0.40	0.45	0.30	0.17	0.22	1.15	0.61	0.17	0.40	1.35	0.91	0.65
Accrued Expenses	3.99	4.19	4.72	5.04	4.85	6.90	8.20	12	11	8.84	9.18	7.84	7.91	8.98	9.06	7.24	7.86	7.63	7.16	6.38	5.07	4.28	4.04	1.80	4.00	0.66	1.09	0.86	0.86	0.46	1.51	1.48	1.15	1.13	2.29	4.18	3.05	3.02	2.80	3.44
Current Portion of Leases	0.06	0.01	0.02	0.04	0.05	0.07	0.02	0.03	0.04	0.05	0.05	0.05	0.04	0.04	0.04	0.04	0.03	0.01	0.01	0.02	0.03	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.03	0	–	–	–	–	–	–	–	–	–
Total Current Liabilities	152	7.31	8.03	136	11	111	35	25	15	13	16	11	9.95	12	13	9.59	11	9.54	9.03	8.30	6.05	4.66	5.40	2.49	4.28	1.32	2.82	1.22	1.32	0.91	2.11	1.65	1.44	2.28	2.97	4.34	3.51	4.36	3.78	4.09
Long-Term Leases	–	–	–	–	–	–	–	–	–	0.01	0.02	0.03	0.04	0.06	0.07	0.08	0.09	0.10	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	0.12	0.01	0.02	0.04	0.05	0.07	0.02	0.03	0.04	0.06	0.07	0.08	0.09	0.10	0.11	0.12	0.12	0.11	0.01	0.02	0.03	0.04	0.05	0.06	0.07	0.08	0.09	0.10	0.11	0.12	0	–	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	0.06	–	0	–	–	–	0	0	0	0.01	0.02	0.03	0.04	0.06	0.07	0.08	0.09	0.10	0	0	0	0	0.01	0.02	0.03	0.04	0.05	0.06	0.07	0.08	0	–	–	–	–	–	–	–	–	–
Total Liabilities	152	146	146	136	133	122	121	121	110	97	88	73	71	63	53	40	41	40	39	29	16	4.66	5.41	2.51	4.31	1.36	2.87	1.28	1.39	0.99	2.11	1.65	1.44	2.28	2.97	4.34	3.51	4.36	3.78	4.09
Preferred Stock	0.48	0.48	0.49	0.49	0.49	0.50	0.50	0.50	0.50	0.50	0.50	0.51	0.51	0.51	0.51	0.51	0.51	0.53	0.53	0.53	–	–	0.53	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Common Stock	0.07	0.07	0.07	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.06	0.05	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.03	0.03
Additional Paid-In Capital	308	305	304	301	299	297	296	295	294	292	292	291	277	276	275	274	273	272	271	270	270	262	262	261	261	260	260	258	258	210	194	193	191	179	173	172	171	170	167	162
Retained Earnings	-447	-438	-433	-427	-419	-411	-402	-390	-378	-366	-354	-344	-330	-321	-310	-299	-290	-281	-271	-263	-255	-246	-240	-232	-226	-220	-216	-211	-208	-205	-196	-193	-190	-186	-181	-178	-174	-169	-164	-159
Shareholders' Equity	-139	-132	-128	-125	-119	-114	-105	-94	-84	-44	-62	-53	-53	-44	-34	-24	-17	-7.92	0.89	7.53	15	17	22	30	35	41	44	48	50	5.12	5.18	7.25	8.05	0.93	-0.53	0.95	4.09	7.91	10	10
Total Equity	-139	-132	-128	-125	-119	-114	-105	-94	-84	-44	-62	-53	-53	-44	-34	-24	-17	-7.92	0.89	7.53	15	17	22	30	35	41	44	48	50	5.12	5.18	7.25	8.05	0.93	-0.53	0.95	4.09	7.91	10	10
Total Liabilities & Equity	15	16	20	13	16	9.53	17	29	28	26	28	22	20	20	21	18	26	34	42	38	33	23	30	34	41	44	48	51	53	7.83	9.01	11	11	4.93	4.16	7.01	9.33	14	16	16
Shares Outstanding(shares)	66	66	65	64	64	63	63	62	62	62	62	62	60	60	59	59	59	59	59	59	59	57	57	57	57	57	57	57	57	46	41	41	41	38	36	36	35	35	33	29

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 26.5%

Financial strength

Current ratio: 0.10
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 8.8%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –